NZ sharemarket up 0.3% ahead of HYEFU

NZ sharemarket up 0.3% ahead of HYEFU
Directionless market awaits data. (Image: Getty)
Graham Skellern
The New Zealand sharemarket had a late revival all thanks to Fisher and Paykel Healthcare, and is looking ahead to strong leads from crunch economic data and interest rate moves. The S&P/NZX 50 Index was up and down all day before taking another leap in the last hour and closing at 12,797.64, up 43.38 points or 0.34%. There were 30.66 million share transactions worth $125.35m.'A big day'David McConnochie, investment adviser with Forsyth Barr, said it was largely a directionless market that Fisher and Paykel Healthcare held...

More Markets

Pacific Edge 'star of the day' on NZX
Markets Market Close

Pacific Edge 'star of the day' on NZX

The S&P/NZX 50 Index closed up 0.17% or 22.50 points.

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price
Markets

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price

Cancer diagnostics company Pacific Edge has announced that the United States' Centers for Medicare & Medicaid Services (CMS) recommended a final “gapfill” price for its Cxbladder Triage Plus.CMS is proposing a price of US$1,328.32 (NZ$2,241.71), which is about 30% higher than...

Briscoe's bottom line squeezed despite flat first-half sales
Retail

Briscoe's bottom line squeezed despite flat first-half sales

Rod Duke expects full-year profits to come in lower than previously signalled.

ANZ's NZ operation may escape worst of 'Nuno-geddon'
Finance

ANZ's NZ operation may escape worst of 'Nuno-geddon'

ANZ NZ’s performance might be its potential saving grace.